Biological feedback correction of respiration during treatment of bronchial asthma

Conclusion

The developed prototype for BF-based respiration correction device allows BF-mediated treatment of BA in pediatric patients to be implemented and basic principles of medical procedure and technical requirements for the procedure and serially produced device to be formulated.

The results of clinical trial of the prototype for the BF-mediated treatment device in pediatric patients with BA gave the following conclusions:

• - the respiratory correction device arrests early symptoms of BA attack without bronchodilators in most pediatric patients with benign and moderate forms of the disease, reduces frequency of BA attacks, prolongs remission, and reduces dosage of prescribed bronchodilators;

• - reduced obstruction and emphysema (as measured spirographically), normalization of blood gas content, and decreased capnographic symptoms of irregular lung ventilation can be regarded as functional criteria of positive dynamics of the disease under the BF correction of respiration;

• - BF correction of respiration in outpatient settings is indicated for patients with benign and moderate forms of atopic BA during acute, post-attack, and inter-attack periods. Such treatment is contraindicated for patients with severe form and during BA attack;

• - BF respiratory correction reduces psychosomatic disorders, anxiety, dependence on bronchodilators, fear of recurrent attack, tearfulness, erethism, and insomnia.